DIALYSIS · CCN 052637

DaVita Burbank Dialysis

Burbank, CA 91504

DialysisProfitDaVita
$5.8M
TOTAL REVENUE
23.8%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.8M
Total costs
$4.4M
Operating income (rev − costs)
$1.4M
Operating margin
23.8%
Total charges
$5.6M
Total treatments
13,550
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8161—
Fistula Rate
DFC_FISTULA_RATE
71.6118—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.7447—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
136.477—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.52——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
15118—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
19.7344—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
16.193—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
28.961—
Standardized ED Visits Ratio
DFC_SEDR
0.9239—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
21.836—